A detailed history of Charles Schwab Investment Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 61,030,403 shares of BMY stock, worth $3.51 Billion. This represents 0.61% of its overall portfolio holdings.

Number of Shares
61,030,403
Previous 59,061,674 3.33%
Holding current value
$3.51 Billion
Previous $2.45 Billion 28.76%
% of portfolio
0.61%
Previous 0.47%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $78.1 Million - $102 Million
1,968,729 Added 3.33%
61,030,403 $3.16 Billion
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $215 Million - $283 Million
5,345,708 Added 9.95%
59,061,674 $2.45 Billion
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $2.03 Billion - $2.3 Billion
42,354,249 Added 372.78%
53,715,966 $2.91 Billion
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $6.54 Million - $7.8 Million
134,815 Added 1.2%
11,361,717 $583 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $65,299 - $73,015
1,128 Added 0.01%
11,226,902 $652 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $8.14 Million - $9.03 Million
-127,692 Reduced 1.12%
11,225,774 $718 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $9.62 Million - $10.9 Million
146,367 Added 1.31%
11,353,466 $787 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $4.85 Million - $5.75 Million
70,887 Added 0.64%
11,207,099 $806 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $40,490 - $23.9 Million
311,466 Added 2.88%
11,136,212 $792 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $13.1 Million - $14.5 Million
-180,727 Reduced 1.64%
10,824,746 $834 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $12.1 Million - $14.5 Million
197,000 Added 1.82%
11,005,473 $804 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $6.92 Million - $8.07 Million
129,007 Added 1.21%
10,808,473 $674 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $19.3 Million - $22.6 Million
326,265 Added 3.15%
10,679,466 $632 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $12.7 Million - $13.8 Million
204,683 Added 2.02%
10,353,201 $692 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $22.1 Million - $24.8 Million
-372,144 Reduced 3.54%
10,148,518 $641 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.14 Million - $1.29 Million
19,751 Added 0.19%
10,520,662 $653 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $38 Million - $42.1 Million
-661,878 Reduced 5.93%
10,500,911 $633 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $464 Million - $542 Million
-8,458,990 Reduced 43.11%
11,162,789 $656 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $1.89 Million - $2.74 Million
-40,694 Reduced 0.21%
19,621,779 $1.09 Billion
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $288 Million - $376 Million
5,861,939 Added 42.48%
19,662,473 $1.26 Billion
Q3 2019

Nov 08, 2019

BUY
$42.77 - $50.71 $15.9 Million - $18.9 Million
371,981 Added 2.77%
13,800,534 $700 Million
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $26.5 Million - $29.3 Million
593,222 Added 4.62%
13,428,553 $609 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $272 Million - $324 Million
6,027,123 Added 88.53%
12,835,331 $612 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $13.3 Million - $17.3 Million
273,010 Added 4.18%
6,808,208 $354 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $13.9 Million - $15.7 Million
251,993 Added 4.01%
6,535,198 $406 Million
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $8.71 Million - $10.9 Million
172,417 Added 2.82%
6,283,205 $348 Million
Q1 2018

May 07, 2018

BUY
$59.92 - $68.98 $13.7 Million - $15.8 Million
229,151 Added 3.9%
6,110,788 $387 Million
Q4 2017

Jan 17, 2018

BUY
$59.94 - $65.35 $15.8 Million - $17.2 Million
263,197 Added 4.68%
5,881,637 $360 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $310 Million - $358 Million
5,618,440
5,618,440 $358 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.